{"cluster": 69, "subcluster": 47, "abstract_summ": "With appropriate anticipation, multidisciplinary head and cancer teams could potentially minimize the impact of this surge and plan for strategies to provide optimal care for patients with head and neck cancer.To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI.The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer.In this article, we focus on recommendations for the surveillance of head and neck cancer patients during and following radiotherapy treatment.Therefore, those caring for patients with head and neck cancer must take action to reduce these negative impacts as the country rallies to overcome the challenges posed by this pandemic.The medical complexity of head and neck cancer management may lead to prolonged delays that worsen treatment outcomes.", "title_summ": "Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID\u201019The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemicPrevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemicThe role of head and neck cancer advocacy organizations during the COVID\u201019 pandemicInpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-OncologyFollow-up and management of head and neck cancer patients during the 2019 novel coronavirus (SARS-CoV-2) disease pandemicModified management mode for colorectal cancer during COVID-19 outbreak \u2013 a single-center experienceSurge after the surge:Impact of the COVID-19 Pandemic on the Management of Head and Neck Malignancies.", "title_abstract_phrases": "To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI.Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemicThe 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer.With appropriate anticipation, multidisciplinary head and cancer teams could potentially minimize the impact of this surge and plan for strategies to provide optimal care for patients with head and neck cancer.Follow-up and management of head and neck cancer patients during the 2019 novel coronavirus (SARS-CoV-2) disease pandemicThe SARS-CoV-2 pandemic has significantly impacted healthcare delivery around the world.In this article, we focus on recommendations for the surveillance of head and neck cancer patients during and following radiotherapy treatment.Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID\u201019The novel coronavirus disease 2019 (COVID\u201019) pandemic continues to have extensive effects on public health as it spreads rapidly across the globe."}